InvestorsHub Logo

iwant2barafter

01/05/18 12:50 PM

#3062 RE: Opti Mist #3061

Very little risk and way too much upside. Loading the boat ??

bUrRpPPP!

01/05/18 3:51 PM

#3067 RE: Opti Mist #3061

These kind of negative one opinion articles are the norm prior to a PDUFA date on bio stocks...Mostly used to cover short positions and/or to go long at a cheap price.

Opti Mist

01/21/18 7:32 AM

#3112 RE: Opti Mist #3061

Key events next week - healthcare
Jan. 19, 2018 3:44 PM ET|By: Douglas W. House, SA News Editor
Noteworthy events in healthcare next week:
Tuesday (1/23): Johnson & Johnson (NYSE:JNJ) Q4 earnings. EMA's Committee for Medicinal Products for Human Use (CHMP) oral hearing on Puma Biotech's (NYSE:PBYI) neratinib marketing application. The Medicines Company (NASDAQ:MDCO) Investor Day.
Wednesday (1/24): Abbott (NYSE:ABT) Q4 earnings. FDA Ad Com meeting on modified-risk tobacco products (NYSE:MO)(two days). FDA action date for Synergy Pharma's (NASDAQ:SGYP) Trulance for IBS-C.
Thursday (1/25): Quarterly earnings for Celgene (NASDAQ:CELG), Biogen (NASDAQ:BIIB) and Dr. Reddy's Labs (NYSE:RDY).
Friday (1/26): Quarterly earnings for Hill-Rom Holdings (NYSE:HRC) and AbbVie (NYSE:ABBV). FDA action date for Aradigm's (NASDAQ:ARDM) Linhaliq for non-CF bronchiectasis. FDA action date for Roche's (OTCQX:RHHBY) Perjeta for HER2+ breast cancer (actual action date is Sunday, 1/28).

Opti